Acetylcholinesterase: 'Classical' and 'non-classical' functions and pharmacology

Current Opinion in Pharmacology

Volumn 5, Issue 3 SPEC. ISS., 2005, Pages 293-302

  Silman, Israel ^a   Sussman, Joel L ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 BIS(4 ALLYLDIMETHYLAMMONIUMPHENYL)PENTAN 3 ONE DIBROMIDE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMYLOID; AMYLOID BETA PROTEIN; CARBAMATE INSECTICIDE; CARBAMIC ACID DERIVATIVE; CHOLINESTERASE INHIBITOR; DONEPEZIL; FASCICULIN; GALANTAMINE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; NEUROPROTECTIVE AGENT; NOOTROPIC AGENT; ORGANOPHOSPHATE INSECTICIDE; PHENANTHRENE DERIVATIVE; PROPIDIUM IODIDE; RASAGILINE; RIVASTIGMINE; SELEGILINE; TACRINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; CATALYSIS; CHOLINERGIC TRANSMISSION; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVITY; ENZYME SUBUNIT; HUMAN; HYDROLYSIS; NEUROMUSCULAR DISEASE; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION;

EID: 18744414554     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.01.014     Document Type: Review

References (73)

1. L. Anglister J.R. Stiles M.M. Salpeter Acetylcholinesterase density and turnover number at frog neuromuscular junctions, with modeling of their role in synaptic function Neuron 12 1994 783-794
2. K. Tai S.D. Bond H.R. MacMillan N.A. Baker M.J. Holst J.A. McCammon Finite element simulations of acetylcholine diffusion in neuromuscular junctions Biophys J 84 2003 2234-2241
3. D.M. Quinn Acetylcholinesterase: Enzyme structure, reaction dynamics, and virtual transition states Chem Rev 87 1987 955-979
4. I. Silman A.H. Futerman Modes of attachment of acetylcholinesterase to the surface membrane Eur J Biochem 170 1987 11-22
5. J. Massoulié The origin of the molecular diversity and functional anchoring of cholinesterases Neurosignals 11 2002 130-143
6. I. Silman J.M. Lyles E.A. Barnard Intrinsic forms of acetylcholinesterase in skeletal muscle FEBS Lett 94 1978 166-170
7. L.G. Magazanik V.V. Fedorov R.A. Giniatullin E.E. Nikolsky V.A. Snetkov Functional role of cholinesterase in different types of neuro-muscular junction In Cholinesterases - Fundamental and Applied Aspects Edited by M. Brzin E.A. Barnard D. Sket 1984 de Gruyter Berlin, New York 229-242
8. I. Silman J.L. Sussman Structural studies on cholinesterases In Cholinesterases and Cholinesterase Inhibitors 2000 Martin Dunitz London 9-25 E. Giacobini
9. P. Taylor Anticholinesterase agents In The Pharmacological Basis of Therapeutics Edited by J.G. Hardman L.E. Limbird P.B. Molinoff R.W. Ruddon A.G. Gilman 1996 McGraw-Hill New York 161-176
10. E. Giacobini Cholinesterase inhibitors: From the Calabar bean to Alzheimer therapy In Cholinesterases and Cholinesterase Inhibitors Edited by E. Giacobini 2000 Martin Dunitz London 181-226
11. J.L. Sussman M. Harel F. Frolow C. Oefner A. Goldman L. Toker I. Silman Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein Science 253 1991 872-879
12. G. Kryger M. Harel K. Giles L. Toker B. Velan A. Lazar C. Kronman D. Barak N. Ariel A. Shafferman et al. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II Acta Crystallogr D Biol Crystallogr 56 2000 1385-1394
13. M. Harel G. Kryger T.L. Rosenberry W.D. Mallender T. Lewis R.J. Fletcher J.M. Guss I. Silman J.L. Sussman Three-dimensional structures of Drosophila melanogaster acetylcholinesterase and of its complexes with two potent inhibitors Protein Sci 9 2000 1063-1072
14. P.G. Layer Comparative localization of acetylcholinesterase and pseudocholinesterase during morphogenesis of the chicken brain Proc Natl Acad Sci USA 80 1983 6413-6417
15. S. Greenfield Acetylcholinesterase may have novel functions in the brain Trends Neurosci 7 1984 364-368
16. H. Soreq S. Seidman Acetylcholinesterase - new roles for an old actor Nat Rev Neurosci 2 2001 294-302
17. E. Krejci F. Coussen N. Duval J.M. Chatel C. Legay M. Puype J. Vandekerckhove J. Cartaud S. Bon J. Massoulié Primary structure of a collagenic tail peptide of Torpedo acetylcholinesterase: co-expression with catalytic subunit induces the production of collagen-tailed forms in transfected cells EMBO J 10 1991 1285-1293
18. A.L. Perrier J. Massoulie E. Krejci PRiMA: The membrane anchor of acetylcholinesterase in the brain Neuron 33 2002 275-285
19. S. Bon F. Coussen J. Massoulié Quaternary associations of acetylcholinesterase. II. The polyproline attachment domain of the collagen tail J Biol Chem 272 1997 3016-3021
20. S. Simon E. Krejci J. Massoulié A four-to-one association between peptide motifs: Four C-terminal domains from cholinesterase assemble with one proline-rich attachment domain (PRAD) in the secretory pathway EMBO J 17 1998 6178-6187
21. H. Dvir M. Harel S. Bon W.Q. Liu M. Vidal C. Garbay J.L. Sussman J. Massoulie I. Silman The synaptic acetylcholinesterase tetramer assembles around a polyproline II helix EMBO J 23 2004 4394-4405
22. B.K. Kay M.P. Williamson M. Sudol The importance of being proline: The interaction of proline-rich motifs in signaling proteins with their cognate domains FASEB J 14 2000 231-241
23. W.A. Lim F.M. Richards Critical residues in an SH3 domain from Sem-5 suggest a mechanism for proline-rich peptide recognition Nat Struct Biol 1 1994 221-225
24. A. Zarrinpar W.A. Lim Converging on proline: The mechanism of WW domain peptide recognition Nat Struct Biol 7 2000 611-613
25. A.G. Engel K. Ohno X.M. Shen S.M. Sine Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction Ann N Y Acad Sci 998 2003 138-160
26. K. Ohno J. Brengman A. Tsujino A.G. Engel Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme Proc Natl Acad Sci USA 95 1998 9654-9659
27. R. Manetsch A. Krasinski Z. Radic J. Raushel P. Taylor K.B. Sharpless H.C. Kolb In situ click chemistry: Enzyme inhibitors made to their own specifications J Am Chem Soc 126 2004 12809-12818
28. J.E. Casida G.B. Quistad Golden age of insecticide research: Past, present, or future? Annu Rev Entomol 43 1998 1-16
29. E. Giacobini Cholinesterases and Cholinesterase Inhibitors 2000 Martin Dunitz London
30. D.M. Du P.R. Carlier Development of bivalent acetylcholinesterase inhibitors as potential therapeutic drugs for Alzheimer's disease Curr Pharm Des 10 2004 3141-3156
31. P. Francotte E. Graindorge S. Boverie P. de Tullio B. Pirotte New trends in the design of drugs against Alzheimer's disease Curr Med Chem 11 2004 1757-1778
32. T. Bunyapaiboonsri O. Ramstrom S. Lohmann J.M. Lehn L. Peng M. Goeldner Dynamic deconvolution of a pre-equilibrated dynamic combinatorial library of acetylcholinesterase inhibitors ChemBioChem 2 2001 438-444
33. W.G. Lewis L.G. Green F. Grynszpan Z. Radic P.R. Carlier P. Taylor M.G. Finn K.B. Sharpless Click chemistry in situ: Acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks Angew Chem Int Ed Engl 41 2002 1053-1057
34. H.C. Kolb M.G. Finn K.B. Sharpless Click chemistry: Diverse chemical function from a few good reactions Angew Chem Int Ed Engl 40 2001 2004-2021
35. M. Harel I. Schalk L. Ehret-Sabatier F. Bouet M. Goeldner C. Hirth P.H. Axelsen I. Silman J.L. Sussman Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase Proc Natl Acad Sci USA 90 1993 9031-9035
36. P. Taylor S. Lappi Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding Biochemistry 14 1975 1989-1997
37. Y. Bourne H.C. Kolb Z. Radic K.B. Sharpless P. Taylor P. Marchot Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation Proc Natl Acad Sci USA 101 2004 1449-1454
38. Y. Bourne P. Taylor Z. Radic P. Marchot Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site EMBO J 22 2003 1-12
39. B.E. Maryanoff Inhibitors of serine proteases as potential therapeutic agents: The road from thrombin to tryptase to cathepsin G J Med Chem 47 2004 769-787
40. H.M. Greenblatt G. Kryger T. Lewis I. Silman J.L. Sussman Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution FEBS Lett 463 1999 321-326
41. C. Bartolucci E. Perola C. Pilger G. Fels D. Lamba Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: Implications for the design of new anti-Alzheimer drugs Proteins 42 2001 182-191
42. P. Bar-On C.B. Millard M. Harel H. Dvir A. Enz J.L. Sussman I. Silman Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine Biochemistry 41 2002 3555-3564
43. C.B. Millard G. Koellner A. Ordentlich A. Shafferman I. Silman J.L. Sussman Reaction of acetylcholinesterase with VX reveals a mobile histidine in the catalytic triad J Am Chem Soc 121 1999 9883-9884
44. A. Mary D.Z. Renko C. Guillou C. Thal Potent acetylcholinesterase inhibitors: Design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series Bioorg Med Chem 6 1998 1835-1850
45. H.M. Greenblatt C. Guillou D. Guénard A. Argaman S. Botti B. Badet C. Thal I. Silman J.L. Sussman The complex of a bivalent derivative of galanthamine with Torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: Implications for structure-based drug design J Am Chem Soc 126 2004 15405-15411
46. G. Kryger I. Silman J.L. Sussman Structure of acetylcholinesterase complexed with E2020 (Aricept): Implications for the design of new anti-Alzheimer drugs Structure Fold Des 7 1999 297-307
47. D. Kaufer A. Friedman S. Seidman H. Soreq Acute stress facilitates long-lasting changes in cholinergic gene expression Nature 393 1998 373-377
48. V.R. Deutsch M. Pick C. Perry D. Grisaru Y. Hemo D. Golan-Hadari A. Grant A. Eldor H. Soreq The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation Exp Hematol 30 2002 1153-1161
49. F.G. Scholl P. Scheiffele Making connections: Cholinesterase-domain proteins in the CNS Trends Neurosci 26 2003 618-624
50. T. Zeev-Ben-Mordehai E.H. Rydberg A. Solomon L. Toker V.J. Auld I. Silman S. Botti J.L. Sussman The intracellular domain of the Drosophila cholinesterase-like neural adhesion protein, gliotactin, is natively unfolded Proteins 53 2003 758-767
51. S. Jamain H. Quach C. Betancur M. Rastam C. Colineaux I.C. Gillberg H. Soderstrom B. Giros M. Leboyer C. Gillberg T. Bourgeron Paris Autism Research International Sibpair Study: Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism Nat Genet 34 2003 27-29
52. F. Laumonnier F. Bonnet-Brilhault M. Gomot R. Blanc A. David M.P. Moizard M. Raynaud N. Ronce E. Lemonnier P. Calvas et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family Am J Hum Genet 74 2004 552-557
53. P.G. Genever M.A. Birch E. Brown T.M. Skerry Osteoblast-derived acetylcholinesterase: A novel mediator of cell-matrix interactions in bone? Bone 24 1999 297-303
54. L.E. Paraoanu P.G. Layer Mouse acetylcholinesterase interacts in yeast with the extracellular matrix component laminin-1beta FEBS Lett 576 2004 161-164
55. I. Darboux Y. Barthalay M. Piovant R. Hipeau-Jacquotte The structure-function relationships in Drosophila neurotactin show that cholinesterasic domains may have adhesive properties EMBO J 15 1996 4835-4843
56. S.A. Botti C.E. Felder J.L. Sussman I. Silman Electrotactins: A class of adhesion proteins with conserved electrostatic and structural motifs Protein Eng 11 1998 415-420
57. P.G. Layer T. Weikert R. Alber Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism Cell Tissue Res 273 1993 219-226
58. S. Bataillé P. Portalier P. Coulon J.P. Ternaux Influence of acetylcholinesterase on embryonic spinal rat motoneurones growth in culture: A quantitative morphometric study Eur J Neurosci 10 1998 560-572
59. K.V. Sharma C. Koenigsberger S. Brimijoin J.W. Bigbee Direct evidence for an adhesive function in the noncholinergic role of acetylcholinesterase in neurite outgrowth J Neurosci Res 63 2001 165-175
60. M. Sternfeld G. Ming H. Song K. Sela R. Timberg M. Poo H. Soreq Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini J Neurosci 18 1998 1240-1249
61. N.C. Inestrosa A. Alvarez C.A. Perez R.D. Moreno M. Vicente C. Linker O.I. Casanueva C. Soto J. Garrido Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme Neuron 16 1996 881-891
62. A.E. Reyes D.R. Perez A. Alvarez J. Garrido M.K. Gentry B.P. Doctor N.C. Inestrosa A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme Biochem Biophys Res Commun 232 1997 652-655
63. M. Bartolini C. Bertucci V. Cavrini V. Andrisano Beta-amyloid aggregation induced by human acetylcholinesterase: Inhibition studies Biochem Pharmacol 65 2003 407-416
64. K.A. Carson C. Geula M.M. Mesulam Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue Brain Res 540 1991 204-208
65. A. Alvarez R. Alarcon C. Opazo E.O. Campos F.J. Munoz F.H. Calderon F. Dajas M.K. Gentry B.P. Doctor F.G. De Mello N.C. Inestrosa Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils J Neurosci 18 1998 3213-3223
66. G.V. De Ferrari M.A. Canales I. Shin L.M. Weiner I. Silman N.C. Inestrosa A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation Biochemistry 40 2001 10447-10457
67. I. Shin I. Silman L.M. Weiner Interaction of partially unfolded forms of Torpedo acetylcholinesterase with liposomes Protein Sci 5 1996 42-51
68. C.E. Felder M. Harel I. Silman J.L. Sussman Structure of a complex of the potent and specific inhibitor BW284C51 with Torpedo californica acetylcholinesterase Acta Crystallogr D Biol Crystallogr 58 2002 1765-1771
69. Y. Bourne P. Taylor P. Marchot Acetylcholinesterase inhibition by fasciculin: Crystal structure of the complex Cell 83 1995 503-512
70. M. Harel G.J. Kleywegt R.B. Ravelli I. Silman J.L. Sussman Crystal structure of an acetylcholinesterase-fasciculin complex: Interaction of a three-fingered toxin from snake venom with its target Structure 3 1995 1355-1366
71. L. Piazzi A. Rampa A. Bisi S. Gobbi F. Belluti A. Cavalli M. Bartolini V. Andrisano P. Valenti M. Recanatini 3-(4- Benzyl(methyl)amino]methyl]p henyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: A dual function lead for Alzheimer's disease therapy J Med Chem 46 2003 2279-2282
72. J. Sterling Y. Herzig T. Goren N. Finkelstein D. Lerner W. Goldenberg I. Miskolczi S. Molnar F. Rantal T. Tamas et al. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease J Med Chem 45 2002 5260-5279
73. M. Yogev-Falach T. Amit O. Bar-Am M. Weinstock M.B. Youdim Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline FASEB J 16 2002 1674-1676